Tekrardan Hoşgeldiniz
Cointime’a Katıl
Giriş Yap
Kayıt Ol
Gelen kutunuzu kontrol edin
Click Therapeutics
About
Click Therapeutics delivers safe and effective digital treatments to patients in need.
- New York,New York,United States
- 101 - 250
- http://www.clicktherapeutics.com
Details
- Last Funding Type
- Debt Financing
- Last Funding Money Raised
- $15M
- Industries
- Biotechnology,Health Care,Medical Device,Pharmaceutical,Therapeutics
- Founded date
- Apr 1, 2012
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Legal Name
- Click Therapeutics, Inc.
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 15, 2022 | Debt Financing | $15M | 1 |
Silicon Valley Bank
|
— | Detail |
| Oct 22, 2021 | Series B | $52M | 8 |
Accelmed
H.I.G. BioHealth Partners
|
— | Detail |
| Dec 1, 2020 | Debt Financing | $30M | 1 |
K2 HealthVentures
|
— | Detail |
| Sep 11, 2020 | Funding Round | $500M | 1 |
Boehringer Ingelheim
|
— | Detail |
| Dec 11, 2018 | Funding Round | $302M | 1 | — | — | Detail |
Investments
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Silicon Valley Bank
|
Yes | Debt Financing |
|
Accelmed
|
Yes | Series B |
|
H.I.G. BioHealth Partners
|
Yes | Series B |
|
Boehringer Ingelheim
|
Yes | Funding Round |
|
|
Yes | Convertable Note |
Health Catalyst Capital
|
— | Series B |
Hikma Ventures
|
— | Series B |
|
K2 HealthVentures
|
— | Series B |
Revelation Partners
|
— | Series B |
Ridgetop Health
|
— | Series B |
Employee Profiles
Acquisition
Click Therapeutics has acquired 1 organizations. Their most recent acquisition was ProGevity Neuroscience on Aug 6, 2012. They acquired ProGevity Neuroscience for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Aug 6, 2012
ProGevity Neuroscience
|
Health Care | acquisition | — | Detail |
